Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Clostridium Stories

2013-10-15 08:30:08

Company's Proprietary Oral Beta-Lactamase Enzyme Successful Evaluation Conducted by FUJIFILM Diosynth Biotechnologies UK Limited ROCKVILLE, Md., Oct. 15, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today the successful completion of the protein expression evaluation with regard to the Company's proprietary oral beta-lactamase enzyme (SYN-004) targeting the...

Scientists Help Identify Possible Botulism Blocker
2013-10-11 12:54:26

UC Irvine Study reveals structure of ‘gateway’ compound in lethal food-borne toxin US and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream. Study leaders Rongsheng Jin, associate professor of physiology & biophysics at UC Irvine, and Andreas Rummel of the Institute for Toxicology at Germany’s Hannover Medical School created a three-dimensional...

2013-08-05 08:27:34

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide SWIFTWATER, Pa., Aug. 5, 2013 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection...

2013-07-25 10:08:59

Now proof of minor added benefit in severe cases or recurrences of Clostridium difficile infections In the commenting procedure on early benefit assessment pursuant to the German Act on the Reform of the Market for Medicinal Products (AMNOG), under certain circumstances drug manufacturers may submit to the Federal Joint Committee (G-BA) additional documents for dossiers. The Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed such additional information for two...

Probiotics Offset Effects Of Antibiotics
2013-05-31 15:53:23

Brett Smith for redOrbit.com - Your Universe Online While antibiotics like penicillin are great for fighting off bacterial infections, they can also wreak havoc on beneficial gut bacteria, leading to diarrhea and other gastrointestinal problems. New research from scientists at the Cochrane Collaboration found that taking a “pre-emptive” probiotic could prevent diarrhea associated with antibiotics when symptoms are caused by the potentially dangerous Clostridium difficile...

2013-05-21 23:01:27

A recent New Zealand Herald article examines numerous concerns surrounding Botox treatments. Dr. Simon Ourian of Epione Beverly Hills says that Botox has been used safely for cosmetic purposes for more than a decade. Los Angeles, CA (PRWEB) May 21, 2013 According to a May 13, 2013 New Zealand Herald article titled “Time to Rethink the Use of Botox,” Botox injections have become the most popular cosmetic procedure in the world since their approval in 2002 (Go to goo.gl/8iYbD)....

2013-05-01 12:27:55

ROSEVILLE, Minn., May 1, 2013 /PRNewswire/ -- William "Bill" McGuire, M.D., former chairman and CEO of UnitedHealth Group, has joined the board of directors of Rebiotix Inc. The Roseville, Minn.-based biotechnology company is pioneering a practical and non-antibiotic treatment for recurrent Clostridium difficile infection (CDI) known as Microbiota Restoration Therapy (MRT). CDI has been linked to 14,000 deaths annually in the US, and has become the most common healthcare-associated...

2013-04-26 08:24:27

Specialised Therapeutics Australia to Launch DIFICID May 14, 2013 JERSEY CITY, N.J., April 26, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Therapeutic Goods Administration, the Australian regulatory body for therapeutic goods such as medicines, has approved DIFICID® (fidaxomicin) tablets for the treatment of confirmed Clostridium difficile infection (CDI) in adults. DIFICID will be available to patients in Australia starting May 14,...

2013-04-25 16:30:46

CHESTERBROOK, Pa., April 25, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the first quarter 2013 on Monday, April 29, 2013 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 8:30 a.m. ET to discuss results and highlights of the first quarter. The presentation slides to be used during the call will be available on the "For Investors" section of the...

2013-04-19 08:25:03

CHERTSEY, England, April 19, 2013 /PRNewswire/ -- Clostridiumdifficile infection (CDI), a potentially fatal disease, is one of the most common healthcare-associated infections[1] Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.[2] In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts...


Latest Clostridium Reference Libraries

0_d6572564d3305dc462f4641398789e11
2011-04-15 13:32:47

Clostridium botulinum is a gram-positive, rod-shaped bacterium that produces neurotoxins, known as botulinum neurotoxins types A-G, that cause the flaccid muscular paralysis seen in botulism. It is the main paralytic agent in botox and is commonly found in soil. It is also an obligate anaerobe, meaning oxygen is poisonous to the cells. Superoxide dismutase helps C. botulinum tolerate traces of oxygen. It was first recognized and isolated in 1895 by Emile van Ermengem. Subsequent outbreaks...

More Articles (1 articles) »